ABDX — Abingdon Health Income Statement
0.000.00%
Last trade - 00:00- £11.62m
- £8.96m
- £6.14m
Annual income statement for Abingdon Health, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | R2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 5.24 | 11.6 | 2.83 | 4.04 | 6.13 |
| Cost of Revenue | |||||
| Gross Profit | 4.43 | 4.14 | -3.59 | 2.08 | 3.68 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 8.55 | 18.3 | 24.4 | 7.63 | 7.51 |
| Operating Profit | -3.31 | -6.72 | -21.5 | -3.59 | -1.37 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3.37 | -6.95 | -21.6 | -3.57 | -1.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.37 | -6.97 | -21.3 | -3.47 | -1.27 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.37 | -6.97 | -21.3 | -3.47 | -1.27 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.37 | -6.97 | -21.3 | -3.47 | -1.27 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.011 | -0.065 | -0.127 | -0.029 | -0.011 |
| Dividends per Share |